SCHEMBL7716698

SCHEMBL7716698

OCCN1CCN(c2nc(N3CCN(c4ccccc4)CC3)ncc2Oc2ccc(Cl)cc2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 3/20 0.46
HTR2A P28223 2/20 0.46
SIGMAR1 Q99720 2/20 0.46
DRD2 P14416 1/20 0.46
DRD3 P35462 1/20 0.46
TMEM97 Q5BJF2 1/20 0.46
MAPT P10636 3/20 0.46
TSHR P16473 3/20 0.46
ALDH1A1 P00352 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
GAA P10253 1/20 0.46
HPGD P15428 1/20 0.46
HSD17B10 Q99714 1/20 0.46
KMT2A Q03164 2/20 0.44
MAPK1 P28482 1/20 0.44
KDM4E B2RXH2 2/20 0.44
TP53 P04637 2/20 0.44
USP2 O75604 1/20 0.44
CASP1 P29466 1/20 0.44
CASP7 P55210 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7714708 0.93 LMNA (0.46) HTR2AMAPTTSHRALDH1A1SMN1; SMN2
SCHEMBL8139672 0.90 MAPT (0.45) HTR1AHTR2ASIGMAR1DRD2DRD3
SCHEMBL7714381 0.90 MEN1 (0.49) HTR1AHTR2ASIGMAR1DRD2DRD3
SCHEMBL7712503 0.89 MEN1 (0.49) HTR2AMAPTTSHRALDH1A1SMN1; SMN2
SCHEMBL7716737 0.89 ALDH1A1 (0.48) HTR2AMAPTTSHRALDH1A1SMN1; SMN2
SCHEMBL7712468 0.89 MEN1 (0.51) HTR2AMAPTTSHRALDH1A1SMN1; SMN2
SCHEMBL7714147 0.88 ALDH1A1 (0.44) HTR2AMAPTTSHRALDH1A1SMN1; SMN2
SCHEMBL7708411 0.86 SRC (0.41) HTR2AMAPTTSHRALDH1A1SMN1; SMN2
SCHEMBL7714501 0.83 LMNA (0.46) HTR1AHTR2ADRD2DRD3MAPT
SCHEMBL7714114 0.82 HTR2A (0.48) HTR2AMAPTTSHRALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US claimed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP claimed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO claimed
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP disclosed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO disclosed